Now a new technology can save your heart and give you an increased life span of 20 years and more. The wait for patients suffering from heart valve diseases is over. With the launch of Trifecta Valve, patients can now see a sign of relief. 69 years old Bhanumati Lakhani, who suffered from aortic heart valve disease, approached Dr Pavan Kumar and was recommended with the best surgery. She got latest generation most expansive bio-prosthetic heart valve for her aortic valve replacement heart surgery. This surgery was performed by senior heart surgeon, Dr Pavan Kumar at Lilavati Hospital.
Dr Pavan Kumar informed, It is the most refined fourth generation bio-prosthesis called TRIFECTA VALVE presently available among all tissue valves. With price tag of Rs. 2,50,000/- per piece, it is expensive but has latest technology incorporated in designing and manufacturing thus providing long lasting durability of 20 years and beyond as claimed by manufacturers. He further adds, This fourth generation prosthesis is probably best for heart patients. The latest trend is towards the use of biological (Tissue Heart Valve) valve similar to western world now, as patients demand drug free post-operative period.
Trifecta Valve was introduced in India in February 2012 after two years of over 1200 implanta-tions all over the world. It is pericardial tissue valve placed on Titenum housing with latest Linx technique anti- calcification treatment for longer durability, providing best haemodynamic even in smallest size among all tissue heart valves.
With introduction of this valve, patients of heart valve disease especially beyond their fifties and ladies in child bearing age will have tremendous relief now. This Trifecta valve eliminates anti-coagulation treatment after implantation. This removes all side effects and consequent complications of anticoagulation treatment in long term for patients with mechanical heart valve prosthesis.
Facts suggest that presently among all heart diseases 35% to 40% patients suffer from heart valve disease. This is mainly due to post Rheumatic infection in childhood or by birth malforma-tions in valves. In elderly patients this can be degenerative disease of valve.
In India, more than 1,50,000 patients undergo heart valve operations of repair and replacement every year. This is usually considered as safe heart operation with mortality of less than 4% in experienced surgeons and good centres.